Injective is excited to announce a strategic partnership with Orion Protocol, a decentralized platform that aggregates the liquidity, order book depth, and trade pairs from every centralized and decentralized digital asset market.
Through this collaboration, we will empower traders to access cross-chain trading across a wide array of digital assets and derivatives as an inaugural broker on Orion’s network. In addition, we plan to explore innovative cross-chain and bridge solutions alongside the Orion team.
As an inaugural broker, Injective plans to be the first liquidity provider of decentralized derivatives on Orion’s aggregated book orders. Looking into the future, this collaboration will bring forth even more opportunities for both Orion and Injective. By partnering with us, Orion will be able to offer derivatives within their trading terminal and swap platform for users to trade traditional digital assets, exotics as well as other derivatives. Furthermore, Orion will be able to leverage our cross-chain and bridge solutions to further improve user experience when trading across distinct layer one protocols.
Injective will be able to use the platform built by Orion to reach new cohorts of traders. Additionally, this collaboration enhances our vision and goal of bringing forth a truly decentralized and scalable derivatives exchange. Not only will this open doors for ORN users, but it will also allow Orion to access new users globally and further improve user experience, bringing forward a faster adoption of Orion’s tech stack.
“We are really excited to join forces with Injective in our common mission of building decentralized technologies for a more inclusive & free financial system that benefits every internet user. Our collaboration will further accelerate growth for the ORN and bring more adoption for our technology stack,” said Alexey Koloskov, Orion Protocol CEO.
Injective will provide Orion users access to a decentralized derivatives platform and Orion will improve Injective’s user experience by giving users access to their cross-chain derivatives. As a result, this partnership will benefit the rapidly growing DeFi industry as a whole.
“Injective and Orion share a common mission of expanding DeFi networks globally while breaking down current financial barriers. We are excited to partner with Orion as it enables us to expand one of Injective’s core use cases around cross-chain derivatives to new user bases,” said Eric Chen, Injective CEO.
This collaboration is an important step for Injective as its platform continues to bring new tokens, technologies, and partners to its decentralized derivatives exchange. As the core visions of both Orion and Injective align greatly, we plan to collaborate closely to bring forward a more secure, flexible, and user-friendly experience to the DeFi space.
About Injective Protocol
Injective Protocol is the first layer-2 decentralized exchange protocol that unlocks the full potential of decentralized derivatives and borderless DeFi. Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. Injective Protocol is backed by a prominent group of stakeholders including Pantera Capital, one of the most renowned venture capital firms in the world, and the leading cryptocurrency exchange, Binance.
Want to learn more about Injective? Join us via the channels below!